首页> 外文期刊>Journal of Inborn Errors of Metabolism & Screening >Enzyme Replacement Therapy With Elosulfase Alfa Decreases Storage of Glycosaminoglycan in White Blood Cells of Patients With Morquio A Syndrome
【24h】

Enzyme Replacement Therapy With Elosulfase Alfa Decreases Storage of Glycosaminoglycan in White Blood Cells of Patients With Morquio A Syndrome

机译:硫磺酶Alfa的酶替代治疗可减少Morquio A综合征患者白细胞中糖胺聚糖的储存

获取原文
           

摘要

Mucopolysaccharidosis IVA (MPS IVA; Morquio A syndrome) is a lysosomal storage disorder caused by a deficient N-acetylgalactosamine-6-sulfate sulfatase activity, leading to cellular storage of undegraded keratan sulfate. Recently enzyme replacement therapy (ERT) was approved for MPS IVA, but some of ERT effects are still unknown. In the present study, we aimed to evaluate the efficacy of elosulfase alfa upon glycosaminoglycan (GAG) storage in peripheral blood white blood cells of patients with MPS IVA treated for 6 months, comparing samples from patients who received weekly infusions of enzyme (ERT-W) versus infusions every other week (ERT-EOW) versus placebo. A significant reduction in GAG storage was observed in both ERT-treated groups, with weekly ERT showing slightly better performance than ERT-EOW.
机译:粘多糖贮积症IVA(MPS IVA; Morquio A综合征)是一种溶酶体贮积病,由N-乙酰半乳糖胺-6-硫酸盐硫酸酯酶活性不足引起,导致未降解硫酸角质素的细胞贮存。最近,酶替代疗法(ERT)已被批准用于MPS IVA,但是一些ERT的作用仍然未知。在本研究中,我们旨在评估环磷酰胺酶对6个月接受MPS IVA治疗的MPS IVA患者外周血白细胞中糖胺聚糖(GAG)储存的疗效,比较每周接受酶输注(ERT-W )与每两周输液(ERT-EOW)与安慰剂之比。在两个ERT治疗组中均观察到GAG储存量显着减少,每周ERT显示的性能略好于ERT-EOW。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号